U.S. Figure Skating announced a partnership with TeachAids, a nonprofit leader in producing award-winning global education innovation, to utilize the CrashCourse concussion resources as part of its education offerings.
TeachAids creates breakthrough technology to solve persistent problems in health education around the world. Its products are designed with input from a team of more than 100 world-class academics, researchers, doctors and athletes associated with leading organizations and institutions including Stanford University, Harvard University and Mayo Clinic, among others.
TeachAids has developed “CrashCourse,” a suite of interactive education products focused on the prevention and treatment of concussions and related mental health issues. This education has been designed to teach athletes, parents and coaches about concussions. CrashCourse products include scientific knowledge to help dispel myths and misconceptions about the concussion recovery process. They also serve as resources for athletic trainers, rehab specialists and physicians.
“The health and wellbeing of our athletes is of utmost importance to our organization. Through this partnership with TeachAids and by offering the renowned CrashCourse concussion products, we are able to double down on the work already being done to keep our participants safe at every level within the sport,” U.S. Figure Skating Executive Director Ramsey Baker said.
“TeachAids is honored to join with highly respected U.S. Figure Skating to serve its athletes, parents and coaches,” said Dr. Piya Sorcar, Founder and CEO of TeachAids. “It has been a pleasure to work with their leadership team and promote safety through education together.”
“We are proud to join TeachAids and offer the renowned CrashCourse concussion products as part of our mission to make sport safer for our participants,” Baker said.
For more information on CrashCourse by TeachAids, its partners, and to view their free curriculum, visit www.CrashCourse.TeachAids.org.
Author
-
Similar Posts
Health-Tech Kellogg India Welcomes Seasoned Marketer Vinay Subramanyam as Head of Marketing for South Asia
Health-Tech CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
Health-Tech Juniper Biologics makes USD $600M acquisition for world’s first cell-mediated gene therapy TG-C LD
